Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.
| Image |  |
|---|---|
| Description | scientific article published on 9 July 2009 |
| Author/s |
author: Gianantonio Rosti Gabriele Gugliotta Michele Baccarani Fausto Castagnetti Giovanni Martinelli Francesca Palandri Simona Soverini Serena Merante Elisabetta Abruzzese Ilaria Iacobucci Marilina Amabile Daniela Cilloni Cristina Papayannidis Ester Orlandi Alessandra Gnani Antonella Gozzini Sabrina Colarossi Stefania Paolini Angela Poerio |
| Publication date | July 9, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |